| Description: |
circHIPK3 is down-regulated in lung cancer tissues and is associated with more advanced tumor characteristics (larger tumor diameter, higher TNM stage, lymph node metastasis). Reduced circHIPK3 expression is linked to enhanced gefitinib resistance in lung adenocarcinoma cells, accompanied by decreased gefitinib-mediated apoptosis, and circHIPK3 shows diagnostic potential by ROC analysis. |